We are live on
!
Find out more
DC
Defender Capital Portfolio holdings
AUM
$308M
1-Year Est. Return
4.52%
This Fund
S&P 500
This Quarter
Est. Return
+16.63%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$20.1M
(+19%)
Cap. Flow
+$4.82M
Cap. Flow
% of AUM
3.86%
Top 10 Holdings %
Top 10 Hldgs %
96.86%
Holding
16
New
1
Increased
9
Reduced
5
Closed
–
Top Buys
| 1 |
STAAR Surgical
STAA
|
+$1.71M |
| 2 |
Monster Beverage
MNST
|
+$1.6M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.47M |
| 4 |
Fortive
FTV
|
+$1.46M |
| 5 |
Enovis
ENOV
|
+$805K |
Top Sells
| 1 |
Danaher
DHR
|
+$3.14M |
| 2 |
Serina Therapeutics
SER
|
+$120K |
| 3 |
Kinder Morgan
KMI
|
+$66.7K |
| 4 |
Winmark
WINA
|
+$32.6K |
| 5 |
Amazon
AMZN
|
+$16.6K |
Sector Composition
| 1 | Healthcare | 44.23% |
| 2 | Financials | 21.31% |
| 3 | Technology | 14.72% |
| 4 | Consumer Staples | 14.05% |
| 5 | Consumer Discretionary | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.06T
| $26.6M | 21.31% |
132,762
+7,274
| +6% | +$1.47M |
|
|
2
Danaher
DHR
$144B
| $20.8M | 16.6% |
179,500
-30,643
| -15% | -$3.14M |
|
|
3
STAAR Surgical
STAA
$1.3B
| $18.5M | 14.83% |
524,686
+48,400
| +10% | +$1.71M |
|
|
4
Fortive
FTV
$18.8B
| $17.7M | 14.13% |
336,556
+29,925
| +10% | +$1.46M |
|
|
5
Monster Beverage
MNST
$94.5B
| $17.6M | 14.05% |
644,490
+55,960
| +10% | +$1.6M |
|
6
Lineage Cell Therapeutics
LCTX
$294M
| $5.57M | 4.46% |
4,214,560
+230,090
| +6% | +$286K |
|
|
7
Enovis
ENOV
$1.54B
| $5.25M | 4.2% |
105,157
+18,360
| +21% | +$805K |
|
|
8
Winmark
WINA
$1.41B
| $3.54M | 2.84% |
20,026
-198
| -1% | -$32.6K |
|
|
9
Kinder Morgan
KMI
$71.7B
| $2.99M | 2.39% |
149,789
-3,572
| -2% | -$66.7K |
|
10
Inovio Pharmaceuticals
INO
$91.3M
| $2.55M | 2.04% |
57,700
+9,275
| +19% | +$467K |
|
|
11
Serina Therapeutics
SER
$31.8M
| $1.32M | 1.06% |
9,042
-819
| -8% | -$120K |
|
12
Compugen
CGEN
$222M
| $1.3M | 1.04% |
311,333
+20,800
| +7% | +$71.4K |
|
13
Apple
AAPL
$4.88T
| $500K | 0.4% |
10,576
+2,896
| +38% | +$123K |
|
|
14
Amazon
AMZN
$2.66T
| $459K | 0.37% |
5,180
-200
| -4% | -$16.6K |
|
15
Cisco
CSCO
$445B
| $232K | 0.19% |
+4,350
| New | +$211K |
|
|
FIT
16
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $117K | 0.09% |
20,000
| – | – |
|
Similar funds
PC
AWA
FUBT
AC
EWM
ICP
ACM
GE
Defender Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Defender Capital held 16 positions worth $125M, up 19% from $105M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Defender Capital deployed $4.82M of net new capital in Q1 2019, opening 1 new position and adding to 9 existing holdings. Its largest new stake was Cisco: 4,350 shares worth $232K.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Danaher, an estimated $3.14M trimmed.
- Defender Capital's largest Q1 2019 buy was Cisco: 4,350 shares worth $232K.
- Defender Capital added most to STAAR Surgical in Q1 2019, an estimated $1.71M increase.
- Defender Capital's biggest Q1 2019 reduction was Danaher, cutting an estimated $3.14M.
- Defender Capital's ten largest holdings make up 97% of its $125M portfolio in Q1 2019.
- Defender Capital opened 1 new position and closed 0 in Q1 2019.
- Defender Capital's portfolio value rose 19% quarter-over-quarter to $125M.
Based on Defender Capital's 13F filing for Q1 2019, filed 22 Apr 2019.